Tetsutaro Nagaoka

1.5k total citations
43 papers, 1.2k citations indexed

About

Tetsutaro Nagaoka is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Tetsutaro Nagaoka has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Tetsutaro Nagaoka's work include Pulmonary Hypertension Research and Treatments (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Nitric Oxide and Endothelin Effects (7 papers). Tetsutaro Nagaoka is often cited by papers focused on Pulmonary Hypertension Research and Treatments (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Nitric Oxide and Endothelin Effects (7 papers). Tetsutaro Nagaoka collaborates with scholars based in Japan and United States. Tetsutaro Nagaoka's co-authors include Masahiko Oka, Ivan F. McMurtry, Sarah A. Gebb, Yoshiteru Morio, Karen A. Fagan, Natalie R. Bauer, Kenneth G. Morris, Noriyuki Homma, Vijaya Karoor and Tsutomu Suzuki and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Journal of Applied Physiology.

In The Last Decade

Tetsutaro Nagaoka

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tetsutaro Nagaoka Japan	16	794	376	342	307	102	43	1.2k
Dominique Rideau France	13	874 1.1×	340 0.9×	288 0.8×	311 1.0×	150 1.5×	18	1.3k
Yoshiteru Morio Japan	16	544 0.7×	353 0.9×	265 0.8×	197 0.6×	130 1.3×	41	940
DJ Stewart Canada	10	813 1.0×	462 1.2×	180 0.5×	478 1.6×	122 1.2×	15	1.2k
Crystal Kantores Canada	20	708 0.9×	313 0.8×	255 0.7×	183 0.6×	225 2.2×	33	1.0k
Michael W. Stoner United States	14	338 0.4×	355 0.9×	314 0.9×	73 0.2×	75 0.7×	28	858
Amy Richter United States	5	695 0.9×	157 0.4×	476 1.4×	186 0.6×	82 0.8×	6	1.1k
Rasa Tamošiūnienė United States	11	718 0.9×	97 0.3×	176 0.5×	176 0.6×	227 2.2×	16	942
Guillaume Gary‐Bobo France	9	320 0.4×	187 0.5×	333 1.0×	137 0.4×	63 0.6×	12	758
Anne‐Marie Barlier‐Mur France	14	763 1.0×	103 0.3×	256 0.7×	231 0.8×	304 3.0×	19	956
Kelley L. Colvin United States	15	460 0.6×	93 0.2×	138 0.4×	228 0.7×	115 1.1×	26	702

Countries citing papers authored by Tetsutaro Nagaoka

Since Specialization

Citations

This map shows the geographic impact of Tetsutaro Nagaoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsutaro Nagaoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsutaro Nagaoka more than expected).

Fields of papers citing papers by Tetsutaro Nagaoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsutaro Nagaoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsutaro Nagaoka. The network helps show where Tetsutaro Nagaoka may publish in the future.

Co-authorship network of co-authors of Tetsutaro Nagaoka

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsutaro Nagaoka. A scholar is included among the top collaborators of Tetsutaro Nagaoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsutaro Nagaoka. Tetsutaro Nagaoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harada, Norihiro, Sonoko Harada, Sumiko Abe, et al.. (2023). Pretreatment Frequency of Circulating Th17 Cells and FeNO Levels Predicted the Real-World Response after 1 Year of Benralizumab Treatment in Patients with Severe Asthma. Biomolecules. 13(3). 538–538. 8 indexed citations

Harada, Norihiro, Sonoko Harada, Tetsutaro Nagaoka, et al.. (2023). Pretreatment circulating MAIT cells, neutrophils, and periostin predicted the real-world response after 1-year mepolizumab treatment in asthmatics. Allergology International. 73(1). 94–106. 6 indexed citations

Suzuki, Yoshifumi, Tetsutaro Nagaoka, Yuichi Nagata, et al.. (2023). Prognostic analysis of pulmonary hypertension with lung parenchymal lesion: Comparison of mortality with and without connective tissue disease. Respiratory Investigation. 62(1). 167–175.

Yoshida, Takashi, Tetsutaro Nagaoka, Yuichi Nagata, et al.. (2022). Periostin‐related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF‐2 signalling. Respirology. 27(7). 529–538. 11 indexed citations

Kato, Motoyasu, et al.. (2020). Atezolizumab‐induced fulminant type 1 diabetes mellitus occurring four months after treatment cessation. Respirology Case Reports. 8(9). e00685–e00685. 9 indexed citations

Suzuki, Kazuhiro, Takuo Hayashi, Keiko Muraki, et al.. (2020). Transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: the severity of cystic lung destruction assessed by the modified Goddard scoring system as a predictor for establishing the diagnosis. Orphanet Journal of Rare Diseases. 15(1). 125–125. 1 indexed citations

Nagaoka, Tetsutaro, Hiroaki Ihara, Ai Nakamura, et al.. (2019). Age is an independent predictor in pathological diagnosis of sarcoidosis: a retrospective analysis of diagnosis by endobronchial ultrasound-guided transbronchial needle aspiration. Journal of Thoracic Disease. 11(5). 2175–2180.

Kato, Motoyasu, et al.. (2016). Bevacizumab‐induced chronic interstitial pneumonia during maintenance therapy in non‐small cell lung cancer. Respirology Case Reports. 4(2). e00151–e00151. 7 indexed citations

Ando, Katsutoshi, Shinji Motojima, Tokuhide Doi, et al.. (2013). Effect of glucocorticoid monotherapy on pulmonary function and survival in Japanese patients with scleroderma-related interstitial lung disease. Respiratory Investigation. 51(2). 69–75. 27 indexed citations

10.

Ohashi, Rina, Motoyasu Kato, Tomonori Sugawara, et al.. (2011). Breakthrough lung Scedosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergillosis associated with monoclonal gammopathy of undetermined significance (MGUS). Nippon Ishinkin Gakkai Zasshi. 52(1). 33–38. 9 indexed citations

11.

Toba, Michie, Tetsutaro Nagaoka, Yoshiteru Morio, et al.. (2009). Involvement of Rho kinase in the pathogenesis of acute pulmonary embolism-induced polystyrene microspheres in rats. American Journal of Physiology-Lung Cellular and Molecular Physiology. 298(3). L297–L303. 15 indexed citations

12.

Homma, Noriyuki, Tetsutaro Nagaoka, Vijaya Karoor, et al.. (2008). Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone. American Journal of Physiology-Lung Cellular and Molecular Physiology. 295(1). L71–L78. 74 indexed citations

13.

Ochiai, Eri, Katsuhiko Kamei, Akira Watanabe, et al.. (2008). Inhalation of Stachybotrys chartarum causes pulmonary arterial hypertension in mice. International Journal of Experimental Pathology. 89(3). 201–208. 14 indexed citations

14.

Takahashi, Fumiyuki, Kôji Uchida, Tetsutaro Nagaoka, et al.. (2008). Isolated congenital spleen agenesis: A rare cause of chronic thromboembolic pulmonary hypertension in an adult. Respirology. 13(6). 913–915. 8 indexed citations

15.

Oka, Masahiko, Vijaya Karoor, Noriyuki Homma, et al.. (2007). Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension. Cardiovascular Research. 74(3). 377–387. 68 indexed citations

16.

Homma, Noriyuki, Tetsutaro Nagaoka, Yoshiteru Morio, et al.. (2007). Endothelin-1 and Serotonin are Involved in Activation of RhoA/Rho Kinase Signaling in the Chronically Hypoxic Hypertensive Rat Pulmonary Circulation. Journal of Cardiovascular Pharmacology. 50(6). 697–702. 57 indexed citations

17.

Morio, Yoshiteru, Noriyuki Homma, Hideki Takahashi, et al.. (2007). Activity of Endothelium-Derived Hyperpolarizing Factor Is Augmented in Monocrotaline-Induced Pulmonary Hypertension of Rat Lungs. Journal of Vascular Research. 44(4). 325–335. 12 indexed citations

18.

Nagaoka, Tetsutaro, Sarah A. Gebb, Vijaya Karoor, et al.. (2005). Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat. Journal of Applied Physiology. 100(3). 996–1002. 87 indexed citations

19.

Nagaoka, Tetsutaro, Karen A. Fagan, Sarah A. Gebb, et al.. (2004). Inhaled Rho Kinase Inhibitors Are Potent and Selective Vasodilators in Rat Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 171(5). 494–499. 207 indexed citations

20.

Sato, Shinichi, Tetsutaro Nagaoka, Minoru Hasegawa, Chihiro Nishijima, & Kazuhiko Takehara. (2000). Elevated Serum KL-6 Levels in Patients with Systemic Sclerosis: Association with the Severity of Pulmonary Fibrosis. Dermatology. 200(3). 196–201. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact